Evidence map›Paper›PMID 42787553›Full record

ArticleFrontiers in microbiology2026

A data-driven universal gut microbiome health assessment: a machine learning framework trained on large metagenomic data.

Bablu Kumar, Erika Lorusso, Bruno Fosso, Graziano Pesole

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Bablu KumarDepartment of Oncology and Hematology-Oncology, Università degli Studi di Milano, Milan, Italy.
Erika LorussoDepartment of Biosciences, Biotechnology and Environment, University of Bari A. Moro, Bari, Italy.
Bruno FossoDepartment of Biosciences, Biotechnology and Environment, University of Bari A. Moro, Bari, Italy.
Graziano PesoleDepartment of Biosciences, Biotechnology and Environment, University of Bari A. Moro, Bari, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The gut microbiota is essential to maintain host physiology, and its disruption (dysbiosis) is associated with a wide range of diseases. Machine learning (ML) offers a powerful tool to model species-level microbiome profiles, but classifiers that reliably separate healthy from diseased individuals across independent cohorts are still lacking. In this study, we developed a ML classifiers trained on 7,452 publicly available stool metagenomes spanning 32 studies and 12 diseases, designed to distinguish healthy individuals (absence of a clinically diagnosed disease) from non-healthy individuals (presence of a clinically diagnosed disease) based on species-level gut microbiome profiles. We trained 16 supervised models combining four algorithms (RF, SVM-LIN, SVM-RBF, and LR-ElasticNet) combined with all feature sets and three feature-selection algorithms. Performance was assessed by F1 score and ROC-AUC on held-out test data and externally validated on 642 samples from six independent cohorts, including previously unseen diseases. On the test set, all models achieved F1 scores of 78-86% and ROC-AUC values of 89-95%. An SVM-RBF model using permutation-based feature selection performed best (F1 = 86.6%, ROC-AUC = 95.5%; healthy F1 = 86.6%, non-healthy F1 = 88.7%). Importantly, external validation confirmed the generalizability of the full-feature SVM-RBF model (overall F1 = 70.6%; ROC-AUC = 84.7%), including unseen disease types such as

Indexed as

dysbiosisgut microbiomehealth-disease classificationmachine learningmicrobial biomarkersmicrobiome-based predictionshotgun metagenomics

Identifiers

PMID42787553
PMCPMC13601785

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.